Method for evaluating patients for treatment with drugs targeting RET receptor tyrosine kinase

Details for Australian Patent Application No. 2007293280 (hide)

Owner AstraZeneca AB

Inventors Wookey, Alan; Ryan, Anderson Joseph; Sherwood, James

Agent Davies Collison Cave

Pub. Number AU-A-2007293280

PCT Pub. Number WO2008/029123

Priority 60/842,766 07.09.06 US

Filing date 6 September 2007

Wipo publication date 13 March 2008

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

19 March 2009 PCT application entered the National Phase

  PCT publication WO2008/029123 Priority application(s): WO2008/029123

23 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007293281-Hydrocarbon recovery process

2007293274-Improvements in or relating to scanners